IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy.
Intravenous iron therapy is widely used in the management of anemia in patients on hemodialysis, and anemia management protocols provide a standardized approach to IV iron therapy. The author's hemodialysis center implemented an initial anemia management protocol in 2004 based on the principles of a continuous quality improvement (CQI) program, detailed by Bowe and Ammel in the Nephrology Nursing Journal in 2005. Successive revision using the CQI process has resulted in additional benefits regarding patient outcomes, which are reported here. This article illustrates the value of a CQI program for maintaining and improving clinical outcomes in patients who have anemia and are undergoing hemodialysis.
Bowe
Deborah
D
Kidney Institute of Wisconsin, LLC, Glendale, WI, USA.
D018798:Anemia, Iron-Deficiency / Q000209:etiology / Q000517:prevention & control*; D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D005293:Ferritins / Q000097:blood; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage*; D006435:Renal Dialysis / Q000009:adverse effects*; D017749:Total Quality Management / Q000379:methods*; D014922:Wisconsin
D006397:Hematinics; D005293:Ferritins; D007501:Iron